

Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of death in the United States, largely caused by cigarette smoking and long-term exposure to air pollutants. While treatments exist to manage symptoms and slow disease progression, a new factor is now emerging as a significant predictor of lung health decline: persistent COPD mucus plugs.
Persistent Mucus Plugs Worsen Lung Function in COPD
A recent study published in The New England Journal of Medicine by researchers at Mass General Brigham has found that patients with COPD who exhibit persistent mucus plugs in their airways experience a notably faster decline in lung function compared to those without them. These mucus plugs—dense secretions that clog the airways—were detected using CT scans during both the initial assessment and again five years later.
Patients with persistent mucus plugs experienced a decline in forced expiratory volume (FEV1) by 23.2ml/year, while those who newly developed plugs at follow-up declined by 17.7ml/year. In contrast, those who either never had plugs or had them resolve by the follow-up maintained more stable lung function.
Resolution of Mucus Plugs Slows COPD Progression
“Mucus plugs can come and go,” explained Dr. Sofia Mettler, lead author and clinical fellow at Brigham and Women’s Hospital. “If the mucus plugs resolve, the patients have a slower lung function decline than those who have a persisting block.”
This underscores the importance of finding ways to dissolve or prevent mucus plug formation. Interestingly, the decline in lung function was even more pronounced in patients who continued or resumed smoking, highlighting the critical role of smoking cessation in COPD management.
Next Steps: From Observational Insight to Clinical Intervention
Senior author Dr. Alejandro Diaz and his team believe that further research—particularly clinical trials—is needed to determine if targeting mucus plugs can directly alter the course of COPD.
As this was an observational study, causation cannot be confirmed, but the evidence strongly supports that resolving mucus plugs could be a therapeutic target. The research team now aims to identify the biological or lifestyle factors that contribute to mucus plug resolution and explore potential interventions.
A Hopeful Outlook for COPD Patients
For patients and clinicians alike, this study offers a new avenue of hope. Understanding and managing COPD mucus plugs may lead to more effective treatment plans, improved quality of life, and slower disease progression—especially for those in early stages of the disease or at high risk due to continued exposure to smoking and pollutants.
For more information: Mettler, S. K., et al. (2025) Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD. New England Journal of Medicine. doi.org/10.1056/NEJMc2502456.
more recommended stories
Vaping and Teen Smoking: UK Study Warns of Rising Risks
A new study published in Tobacco.
Targeting Cancer Cell Memory Boosts Chemotherapy
Researchers double chemotherapy effectiveness through chromatin.
PFAS Exposure Linked to Increased Type 2 Diabetes Risk
Investigating the Metabolic Impact of Forever.
Gecko-Inspired Nanoparticles Offer New Direction in Localized Cancer Therapy
Nature-Inspired Nanoparticles Deliver Precision Chemotherapy Researchers.
Staphylococcus Shows Complex Enzyme Redundancy, Study Finds
A Bacterial Pathogen That Refuses to.
Can Routine Vaccines Help Combat Antibiotic Resistance?
A growing body of evidence now.
T-bet and the Genetic Control of Memory B Cell Differentiation
In a major advancement in immunology,.
Ultra-Processed Foods May Harm Brain Health in Children
Ultra-Processed Foods Linked to Cognitive and.
Parkinson’s Disease Care Advances with Weekly Injectable
A new weekly injectable formulation of.
Brain’s Biological Age Emerges as Key Health Risk Indicator
Clinical Significance of Brain Age in.
Leave a Comment